Skip Navigation LinksHome Press releases Chronic Ailments and Infectious Diseases to drive IVD Market
press release details
Chronic Ailments and Infectious Diseases to drive IVD Market
Date: 8 October 2017

In-vitro diagnostics (IVD) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.


The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.


There has been continuous surge in the patients suffering from chronic ailments such as cancer. Such disease requires regular diagnosing in order to keep a tab of disease progression and pathogenesis. Thus, rising cases of such diseases will push the demand for more in-vitro diagnostic devices especially in POC, Immunochemistry and molecular diagnostics segments. Further, rising incidence of infectious diseases such as several STDs (HIV, syphilis, gonorrhea and chlamydia), Hantavirus pulmonary syndrome, Lyme disease, and hemolytic uremic syndrome, zika virus and many more have promulgated the need for early and effective diagnosis. This has resulted in the increased demand for IVDs throughout the globe and has become one of the primary growth driver for this market.


The report “Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.


About Us    |    PRESS RELEASES    |    Research Reports    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.